-
إرشادات بشأن لماذا يستمر السعال بعد الإنفلونزا أطباء يكشفون طرق تخفيفه
-
Dortmund sink Stuttgart to climb to Bundesliga summit
-
McIlroy two shots off the lead at Wentworth after eagle on 18
-
Trump says will not tolerate attempts to slow AI growth
-
اتحاد الكرة يعرض تفاصيل موعد إنطلاق بطولة كأس الألف شهيد في غزة
-
Martinez brace saves Inter in Serie A top-two clash with Roma
-
'It has to stop': runners protest women's murders in S.Africa district
-
Rosenior abused but guides Paris FC past old club Strasbourg
-
تقرير حول مكتب الإعلام الدولي في دولة قطر يرد على الادعاءات الكاذبة والتقارير الملفقة في وسائل الإعلام الإسرائيلية
-
تقرير حول موهبة مانشستر يونايتد في برشلونة للتفاوض
-
Fire erupts near Riyadh airport as Houthis claim strikes
-
Seven-try Lyon beat Pau, climb to Top 14 summit
-
Cuba works to restore power after another blackout
-
تقرير حول ليسلم نفسه للاحتلال معتقل منذ 2007 في سجون السلطة
-
Brighton defeat a 'big lesson' against complacency for Arsenal, says Arteta
-
سيول تجدد تأكيد لواشنطن عزمها المساهمة في استعادة حرية الملاحة بمضيق هرمز
-
تقرير حول مجلس الأمن يدين «بأشد العبارات» هجمات الحوثيين المستمرة على المملكة ويؤكد حقها الأصيل في الدفاع عن النفس
-
England thrash Sri Lanka again to return to top of T20 rankings
-
Thousands protest inaction over climate crisis in Switzerland
-
ملياردير روسي موّل جانباً من زفاف نجل ترمب... والرئيس الأميركي يجدد تأكيد سداد الأموال
-
Arsenal thrashed by Brighton, sorry Spurs lose again
-
تقرير حول سوريا: توقيف ضباط سابقين يُشتبه بمسؤوليتهم عن غارات جوية خلال عهد الأسد
-
Carapaz out of cycling world championships
-
ملف خادم الحرمين يوجه بناءً على ما رفعه ولي العهد بإطلاق اسم الأمير مساعد بن عبدالرحمن على الجامعة السعودية الإلكترونية
-
تقرير حول سيول: تصريح الرئيس حول عدم التدخل في الحرب ليس رفضاً لطلب ترمب بشأن هرمز
-
South Korea, Austria qualify for Davis Cup finals
-
مشهد سمير سرياني لـ«الشرق الأوسط»: أحضّر لفيلم لبناني اجتماعي يتناول همومنا بقالب كوميدي
-
'Fragile' Tottenham beaten by Aston Villa despite late rally
-
Seare shocks Ingebrigtsen to win world 5km gold
-
Mourinho hails Real Madrid grit before Atletico derby clash
-
ملف البنيان: تسمية الجامعة السعودية الإلكترونية باسم «الأمير مساعد بن عبدالرحمن» تُجسّد عناية القيادة بالتعليم وتكريم رجالات الدولة
-
Brigitte Bardot widower slams sale of star's belongings
-
Martin wins Austrian MotoGP sprint after Acosta crash
-
Aston Villa compound Tottenham's misery despite late rally
-
Japan edge Fiji to win Pacific Nations Cup
-
حصيلة من يملك جسد اللاعب ورسائله؟ قميص سبتة يتحول إلى نقاش أكبر من السياسة
-
تقرير حول وصول حرب أوكرانيا إلى القطب الشمالي ينذر بتصاعد التوتر بين القوى النووية
-
Asian Games offer 'deepest apologies' for South Korea anthem blunder
-
Black smoke, flames rising near Riyadh airport: residents to AFP
-
تطورات "سي أن أن": تقرير بالذكاء الاصطناعي كاد يشعل حرباً بين أميركا والصين
-
قراءة في مجلس شباب «موانئ دبي العالمية» يناقش دور الخبرات والأفكار في تحسين العمليات
-
Inter Milan and Italy icon Mazzola dies aged 83
-
تقرير حول وفد باكستاني إلى إيران قريباً لكسر جمود المفاوضات واحتواء التوتر في اليمن
-
UK actor Naomi Watts honoured at Spain film festival
-
قراءة في 1000 تاجر جزائري فقط يعتمدون الدفع الإلكتروني
-
Saudi capital issues first air raid alert since renewed fighting in Yemen
-
Japan emperor declares Asian Games open after turbulent build-up
-
Martin edges title rival Marquez for Austrian MotoGP pole
-
Asian Games open with unity message after troubled build-up
-
Indonesia accepts Malaysia's help to tackle wildfires
Publicis settles opioid case with US states for $350 mn
Publicis Health will pay $350 million to settle charges from US states that its "predatory and deceptive marketing strategies" worsened the opioid epidemic, New York's top prosecutor said Thursday.
Publicis Health, part of the French advertising giant Publicis, worked with Purdue Pharma between 2010 and 2019 on marketing material to promote OxyContin and other drugs, New York Attorney General Letitia James said in a press release.
She said the agreement was the first with an advertising agency for its role in the opioid epidemic.
"For a decade, Publicis helped opioid manufacturers like Purdue Pharma convince doctors to overprescribe opioids, directly fueling the opioid crisis and causing the devastation of communities nationwide," James said.
Publicis said in a statement the settlement "is in no way an admission of wrongdoing or liability."
Publicis Health created pamphlets and brochures promoting OxyContin as "safe and unable to be abused," said the New York press release.
Other "aggressive" marketing efforts included working with McKinsey consultants on a program to target doctors who prescribed the most OxyContin with calls touting the drug, according to James.
The settlement distributes funds nationally, with New York garnering $19.2 million of the total, James said.
Publicis described the opioid work as originating with Rosetta, a digital marketing firm the French company acquired in 2011 and shut down 10 years ago.
Rosetta's work on opioids employed tools and language "expressly" approved by US health officials, Publicis said.
It involved communications with health care providers, not patients, the company said.
"Rosetta's role was limited to performing many of the standard advertising services that agencies provide to their clients, for products that are to this day prescribed to patients, covered by major private insurers, Medicare, and authorized by State Pharmacy Boards," Publicis said.
"We recognize the broader context in which that lawful work took place. The fight against the opioid crisis in the United States requires collaboration," the company said.
"We are committed to playing our part. That is why we worked to reach this agreement, and why we are also reaffirming our long-standing decision to turn down any future opioid-related projects."
Of the $350 million in the settlement, $343 million will go for payments to US states and territories and $7 million for legal feels, Publicis said.
Since 1999, more than 800,000 people have died from an overdose involving any opioid, including prescription and illicit opioids, according to the Centers for Disease Control and Prevention.
Y.Shaath--SF-PST